Alkem Laboratories Limited

ALKEM.NS·NSE
Compare
5,015.00+11.00 (+0.22%)today
At close: Oct 21, 3:29 PM IST · May be delayed up to 15 min · INR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close5,004.00
Open4,979.00
Day range4,891.505,050.50
52-week range4,891.505,933.50
Off day high−0.70%
Off 52-week high−15.48%
Volume279.11K
Avg. volume (3M)137.08K
Market cap599.62B
EPS (TTM)180.44
Forward P/E22.41
P/E ratio (TTM)27.79
Dividend yield0.40% (20.00)
Beta (5Y)—
Shares outstanding119.57M
Short interest—
Earnings dateAug 14, 2026 (est.)
Analyst target—
Profit margin—

Against its peers

Compare in full ›
ALKEM.NS APLLTD.BO AKUMS.BO AUROPHARMA.NS GRANULES.BO LAURUSLABS.BO
Market cap 599.62B 154.92B 106.04B 908.41B 194.90B 1.09T
P/E (TTM) 27.8 22.3 36.4 24.7 35.7 99.5
Forward P/E 22.4 16.1 20.3 16.9 26.8 67.1
Price/book 4.3 2.7 3.2 2.4 4.9 20.5
Dividend yield 0.40% 1.52% 0.14% — 0.26% 0.12%
1-year change −9.58% −15.06% +53.27% +47.52% +0.63% +120.17%
Today +0.22% −0.26% −2.40% −2.63% −0.43% −2.44%

The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.

Latest news

All ALKEM.NS news ›
Kalkine India·Positive

Alkem Laboratories (NSE:ALKEM) Senior Management Appointment 2026

Kalkine India Alkem Laboratories (NSE:ALKEM): Who Are the Two Senior Leaders Appointed on 12 October 2026? Source: Krish Capital Pty Ltd Alkem Laboratories (NSE:ALKEM) disclosed on 12 October 2026, under Regulation 30 of the SEBI LODR…

From articles in the 4Search news index.

In the news

4mentions in 30 days
4with it in the headline
Negativesentiment

Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 4 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use.